Literature DB >> 31372456

Data on the association between age at natural menopause and physical function in older women from the International Mobility in Aging Study (IMIAS).

M P Velez1,2, N Rosendaal1, B Alvarado2, S da Câmara3, E Belanger4, C M Pirkle5.   

Abstract

Women experience worse physical function and greater physical decline than men at similar ages. These sex differences are heterogeneous across settings and plausibly linked to gender inequality, with evidence of increasing disadvantage for women in increasingly iniquitous societies. As described in "Age at natural menopause and physical function in older women from Albania, Brazil, Colombia and Canada: A life-course perspective" [Velez et al., 2019] we assessed the association between age at natural menopause (ANM) and objectives markers of physical function (i.e., gait speed and grip strength) in older women from the International Mobility in Aging Study (IMIAS). For all sites combined, women with ANM ≥55 had higher gait speed than those with ANM 50-54. Women with ANM <40 had significantly lower grip strength compared with all other groups. In this article, we describe the region-specific associations between ANM, gait speed, and grip strength in 775 women aged 65-74, from the Southeastern European site (Tirana, Albania), Latin American sites (Manizales, Colombia and Natal, Brazil), and Canadian sites (Kingston, Ontario and Saint-Hyacinthe, Quebec). In region-specific analyses, ANM was associated with grip strength in Albania and Latin America and with gait speed in Albania only. No associations were observed in Canada.

Entities:  

Year:  2019        PMID: 31372456      PMCID: PMC6660581          DOI: 10.1016/j.dib.2019.103811

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications table The data can be used to understand the association between ANM and measures of physical function in an international, community-based sample of older women from five diverse contexts (Albania, Brazil, Colombia and Canada). These results may also be useful in comparative work with other cohorts to better understand how life-course events modify the association between ANM and physical function in diverse contexts. Our model of analyses can be used for other researchers interested in the assessment of the association between ANM and physical function from a life-course perspective in diverse contexts.

Data

The data presented in this article are tables of analyzed data form the International Mobility in Aging Study (IMIAS), a population-based prospective cohort study amongst community-dwelling older adults with sites in 5 cities: 2 in Canada (Kingston and Saint-Hyacinthe), and one in each of the following: Colombia (Manizales), Brazil (Natal), and Albania (Tirana). Funded by the Canadian Institutes of Human Research (CIHR), as part of the Institute of Aging strategic initiative on mobility in aging, IMIAS includes substantial socio-economic and reproductive history data (e.g., age at natural menopause, pregnancy history, use of hormone replacement therapy). In addition, IMIAS collected objective measures of physical function (i.e., gait speed and grip strength) in women aged 65–74. A detailed description of the recruitment and study procedures for the IMIAS can be obtained from Gomez et al. [2] Institutional ethics review board approval was obtained from the participating sites. Written informed consent was obtained from all participants. In this paper we present the following region-specific results: Population characteristics by ANM (Tables 1A, 1B, 1C); distribution (or mean) of ANM and population characteristics by gait speed (Table 2A); and grip strength (Table 2B). We also present multivariate linear regression models of the association between ANM and gait speed (Table 3A), and ANM and grip strength (Table 4A).

Experimental design, materials, and methods

Study population

The IMIAS study has been described elsewhere [2]. The study website contains details about the study design, data collection, sample strategies, researchers, publications, and contact information for researchers interested in conducting analyses with the IMIAS data. http://www.imias.ufrn.br/about.htm.

Methods and statistical analysis

The exposure variable, Age at Natural Menopause was obtained by questionnaire data, and recorded in years. The outcomes, Gait speed and grip strength, were obtained using standardized protocols as described in detail in the Short Physical Performance Battery (SPPB) website (http://www.grc.nia.nih.gov/branches/leps/sppb/index.htm). Details about covariates, and categories used according to each region are described in Ref. [1]. Descriptive analyses included site-specific comparison of covariates by age at menopause, and gait speed and grip strength using chi2 for categorical variables, and one-way ANOVA for continuous variables. Linear regressions were performed to assess the relationships between ANM and gait speed and grip strength specific to each region. To select the covariates relevant to each region and obtain the most parsimonious model, we used a backwards selection procedure. Statistical analysis was conducted using STATA, version 14..

Financial support

This work was supported by CIHR (Canadian Institute for Health Research) grant: ACD 151286.

Author contributions

Author contributions for this project are detailed in Ref. [1].

Specifications table

Subject areaObstetrics, Gynecology and Women's Health
More specific subject areaMenopause
Type of dataTables
How data was acquiredPopulation-based prospective cohort study
Data formatAnalyzed
Experimental factorsData came from the sub-sample of women from the International Mobility in Aging Study (IMIAS), categorized by research site.
Experimental featuresAssociation between age at natural menopause and measures of physical function (gait speed, grip strength), taking into account socioeconomic factors (education, income, and socio-economic and social adversities and childhood, smoking, BMI, hormone replacement therapy)
Data source locationTirana (Albania), Natal (Brazil), Manizales (Colombia), Kingston (Ontario, Canada), and Saint-Hyacinthe (Quebec, Canada)
Data accessibilityData are with this article
Related research articleVelez M.P, Rosendaal N, Alvarado B, da Câmara S, Belanger E, Pirkle C. Age at natural menopause and physical function in older women from Albania, Brazil, Colombia and Canada: A life-course perspective. Maturitas 2019 April; 122: 22–30. doi.org/10.1016/j.maturitas.2018.12.015[1]
Value of the data

The data can be used to understand the association between ANM and measures of physical function in an international, community-based sample of older women from five diverse contexts (Albania, Brazil, Colombia and Canada).

These results may also be useful in comparative work with other cohorts to better understand how life-course events modify the association between ANM and physical function in diverse contexts.

Our model of analyses can be used for other researchers interested in the assessment of the association between ANM and physical function from a life-course perspective in diverse contexts.

  3 in total

1.  Age at natural menopause and physical functioning in postmenopausal women: the Canadian Longitudinal Study on Aging.

Authors:  Maria P Velez; Beatriz E Alvarado; Nicole Rosendaal; Saionara M da Câmara; Emmanuelle Belanger; Harriet Richardson; Catherine M Pirkle
Journal:  Menopause       Date:  2019-09       Impact factor: 2.953

2.  Effects of Exercise Training on Anabolic and Catabolic Hormones with Advanced Age: A Systematic Review.

Authors:  Abderraouf Ben Abderrahman; Anthony C Hackney; Hassane Zouhal; Ayyappan Jayavel; Kamalanathan Parasuraman; Lawrence D Hayes; Claire Tourny; Fatma Rhibi; Ismail Laher
Journal:  Sports Med       Date:  2021-12-22       Impact factor: 11.928

3.  The Effects of 12 Weeks of a Combined Exercise Program on Physical Function and Hormonal Status in Elderly Korean Women.

Authors:  Ji Yu Im; Hyun Seok Bang; Dae Yun Seo
Journal:  Int J Environ Res Public Health       Date:  2019-10-30       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.